BD VERITOR SYSTEM FOR RAPID DETECTION OF FLU A + B by BD Diagnostics BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, and swab in transport media ...

Becton, Dickinson and Co. (BD) said today that it acquired its partner and key supplier in developing the BD Veritor™ System, privately held Alverix, in a $40 million deal designed to grow BD’s ...

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...

Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...

As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD Veritor™ System for Rapid Detection of SARS-CoV-2*. This ...

The first shipment of 1.2 million SARS-CoV-2 Assays for use on the BD Veritor™ Plus System to be delivered in The Netherlands by mid-November For Product Enquiries and How to Order:All BD SARS-CoV-2 ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the receipt of an order from the Dutch Ministry of Health for 9.2 million of its rapid, point-of-care, ...

BD Diagnostics, a segment of Becton, Dickinson and Co., has announced it has received FDA clearance for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor system for ...

Becton, Dickinson and Company BDX, popularly known as BD, received emergency use authorization (“EUA”) from the FDA for a new, rapid antigen test, which can simultaneously identify SARS-CoV-2, ...